The increasing resistance of human and animal bacterial pathogens to a wide spectrum of antibiotics has become an emerging problem in the 21st century (1). In view of the slow progress in the development of antibiotic classes that can overcome drug-resistance mechanisms, the next generation of safe and effective antimicrobial drugs is likely to be The objective of this study was to screen extracts of twenty Eastern European medicinal plants, using wild-type and reporter Chromobacterium violaceum bioassays, for novel components that target bacterial cells and their quorum sensing (QS) communication systems. Three types of activity and their combinations were revealed: (i) direct antimicrobial growth-inhibitory activity, (ii) non-specific and specific pro-QS activities, (iii) anti-QS activity. Among seven plant extracts showing direct growth-inhibitory activity, the strongest effect was shown by Arctostaphylos uva--ursi (bearberry) leaves. Many plants stimulated violacein production by wild-type C. violaceum ATCC 31532 in a non-specific manner, and only the herb Bidens tripartita (three-lobe beggarticks) contained compounds that mimic acyl-homoserine lactone and operated as a QS agonist. Anti-QS activity was found in eleven plants including Quercus robur (oak) cortex, Betula verrucosa (birch) buds and Eucalyptus viminalis (Manna Gum) leaves. Subsequent statistical analysis showed differences between antimicrobial and anti-QS activities, whereas both activities were defined by phylogenetic position of medical resource plant. Finally, extract from Quercus robur cortex revealed at least two fractions, showing different anti-QS mechanisms. These data confirm that multicomponent anti-infectious mechanisms are used by plants, which may be useful for drug development.
based on novel sources and strategies (2) . In particular, medicinal plants used by traditional (folk) medicine for infection control might represent a rich bio-resource of genuine antimicrobial compounds acting upon novel microbial targets (3) .
Early studies of medicinal plant drug discovery focused mainly on their direct antimicrobial potential (4) , which has led to investigation of their mechanisms of action and to isolation of diverse active compounds (5) . However, much less attention has been paid to alternative medicinal plant anti-infection properties that act on microbes by targeting cell--to-cell communication, also known as quorum sensing (QS) (6) . This phenomenon is mediated via small signaling molecules (autoinducers) constantly produced and released by bacteria, which upon reaching a critical threshold concentration, bind to receptors and regulate the expression of target genes (7) . Although there are a number of different QS paradigms, the most widely used by Gram-negative bacteria is the LuxI/R system, where the LuxI proteins synthesise the signal molecule acyl-homoserine lactone (AHL), and the LuxR receptor proteins induce the expression of QS-target genes following AHL binding (8) . In this context, it is important that QS activates virulence factor genes (9) and also that LuxI/R systems in human, animal and plant pathogens are similar (10) . Thus, the discovery of QS represents a novel target for antimicrobial drugs and potential plant-produced QS-regulating agents directed against plant-associated bacterial communication systems might provide a novel approach to controlling bacterial infection in humans and animals (11) .
The first plant-produced QS inhibitor was isolated from a red macroalga, Delisea pulchra, in which halogenated furanones block AHLs via competitive inhibition and destabilisation of the LuxR receptor (12) . Recently, anti-QS properties have also been identified in terrestrial plants from southern Florida (13) and India (14) and also in herbs used in traditional Chinese (15) and oriental (16) medicine.
The objective of this study was to screen Eastern-European medicinal plants for their direct (growth inhibition) and indirect (QS-regulated) activities. Antibacterial potential was analysed by examining aqueous and ethanol plant extracts using Chromobacterium violaceum, a Gram-negative facultatively anaerobic beta-proteobacterium, which is abundant in soil and water ecosystems and occasionally becomes an aggressive opportunistic pathogen (17) . Similarly to other clinically significant multidrug-resistant microorganisms, C. violaceum shows resistance against numerous antibiotics and drug efflux pump genes (18) and thus represents a model for antibacterial screening. C. violaceum also uses a LuxR/I-type QS system (19) , where CviI is an N-hexanoyl-L-homoserine lactone (C 6 -AHL) synthase, and CviR is a cytoplasmic receptor protein (DNA) binding transcription factor) that activates gene expression following binding to a diffusible autoinducer C 6 -AHL (20) . As the purple pigment violacein is under the control of this system, the inhibition of pigment production indicates the presence of anti-QS activity; therefore, C. violaceum bioassays are suitable for investigations of this type (13) (14) (15) (16) (17) .
EXPERIMENTAL

Plant material and extract preparation
Different parts of twenty herbs, flowers and trees were collected for antibacterial and quorum sensing-regulating activities screening (Table I ). The plants were selected based on their efficacy in Eastern-European traditional medicine as antiinflammatory drugs and cures for infection-associated diseases (skin lesions, wounds, respiratory disorders, diarrhea, etc.) according to the instructions accompanying commercially available preparations. They were purchased from Russian ethnopharmaceutical companies as dried leaves, flowers, fruits, rhizomes, buds, propagules and cortex material. The plant material was ground to a fine powder using an electric mill and extracted using water or ethanol. For aqueous extracts, 6 g of each sample was added to 50 mL of hot sterile distilled water. Depending on whether the tissue was soft or tough, this was boiled for 15 min (leaves, flowers), or for 30 min (rhizomes, cortex) and cooled at room temperature for 10-15 min. Primary aqueous extracts were centrifuged at 1000×g for 10 min to remove particulate matter; the supernatants were collected and filtered through a 0.2-µm pore size polyethersulfone (PES) syringe filter (Membrane Solutions LLC, USA) into autoclaved vials to ensure sterility of the final samples. For ethanolic extracts, the plant powder was added to 45 % (V/V) ethanol (3 g dry mass per 25 mL), allowed to stand for 24 h at room temperature before centrifugation and upper phase filtration as above. Final samples were stored as 1-mL aliquots at +4°C until further analysis. Antiinflammatory, for treatment of skin diseases and eczema, epilepsy, respiratory problems: bronchitis, asthma and cold symptoms, also a diuretic, leading to its use in treating rheumatism and cystitis Table I . Continued
Separation of bioactive fractions from plant extracts
The rotary evaporated dried plant extracts (5 mg) were dissolved in 25 mL of 0.1 % trifluoroacetic acid (TFA) and applied to a Synchroprep RP-P C8 phase (SynChrom Inc., USA) 5-mL column. After elution of all un-bound compounds, a total hydrophobic fraction was eluted with 65 % acetonitrile in water by the addition of 0.1 % TFA. Absorbance was monitored at 280 nm at a flow rate of about 2 mL min -1 . Acetonitrile was evaporated in a Speedvac vacuum centrifuge (Savant, USA). The fractions were lyophilized (Labconco, USA) and then dissolved in sterile distilled water for subsequent bioactivity analyses.
Bacterial strains and culture conditions
The wild-type strain C. violaceum ATCC 31532 was purchased from the American Type Culture Collection (LGC Standards, UK). This strain uses a LuxI/R-type quorum sensing system (20) that produces and responds to the cognate autoinducer C 6 -AHL, positively controlling a vioABCDE-operon (21) . Expressed at high cell density, VioA-E proteins perform enzymatic oxidation and coupling of two molecules of tryptophan to give a rearranged pyrrolidone-containing scaffold in the resulting purple pigment violacein (22) . The other biomonitor strain, C. violaceum NCTC 13274, was acquired from the National Collection of Type Cultures (Health Protection Agency, UK). This mini-Tn5 mutant of the wild-type strain has an insertion in the cviI gene and is unable to produce its own autoinducer but responds to exogenous active signal molecules and produces the characteristic purple pigment violacein following incubation with C 6 -AHL. Thus, the wild--type strain recognises anti-QS compounds, including inhibitors of AHL signal generation and reception, whereas the mutant (reporter) strain is reactive to the inhibition of AHL signal reception only, which in both cases leads to inhibition of violacein production and makes these strains ideally suitable for anti-QS activity screening (23) .
Both bacterial strains were stored as 40 % glycerol stocks at -20°C and were cultured in Luria-Bertani (LB) broth medium (AppliChem GmbH, Germany) with 10 mg mL -1 glucose at 27°C prior to use.
Bacterial growth inhibition and violacein production screening assay
The integral agar-diffusion assay was used to detect both antimicrobial and anti-QS activity of the medicinal plant extracts by means of double layer culture plates. Briefly, 5 mL of warm molten 0.5 % LB agar was inoculated with 100 mL of freshly prepared C. violaceum ATCC 31532 or C. violaceum NCTC 13274 culture. Mutant strain was used in two modifications: without exogenous signal or supplemented with 5×10 -7 mol L -1 C 6 -AHL (Cayman Chemical Company, USA). Agar and inoculum were gently mixed and placed immediately over the Petri dish, which was previously overlaid with layer (10 mL) of 1.5 % LB-agar. Solidified agar plates were punched with a 5-mm diameter flame-sterilised cork borer and were kept undisturbed for 30 min for absorption of excess moisture. The wells were filled with 30 mL of appropriate aqueous or ethanolic plant extracts with an equal amount of either sterile distilled water or 45 % ethanol used as a negative control. In some experiments, plant extract mixtures and separated compounds were tested. The assay plates were incubated overnight at 27°C for 24-48 h and were then examined for culture growth and violacein production.
Direct antimicrobial activity was determined as the growth inhibition (gi) area around wells and was calculated as S gi = pr gi 2 -pr w 2 , where r gi is the radius (mm) of the area devoid of bacterial growth and r w is the well radius (mm). The anti-QS activity was detected by pigment inhibition (pi) as a colorless but viable halo on a purple background around the growth inhibition zone and was calculated as S pi = pr pi 2 -pr gi 2 -pr w 2 or as a colorless halo around the well without growth inhibition and calculated as S pi = pr pi 2 -pr w 2 ( Fig. 1) .
RESULTS AND DISCUSSION
Antibacterial activity of plant extracts against C. violaceum
To validate the traditional ethnopharmocological uses of the tested plants as direct antibacterial agents, aqueous and ethanolic extracts were applied in the radial growth inhibition assay against wild-type C. violaceum ATCC 31532 and reporter C. violaceum NCTC 13274 strains (Table II) .
Among the plant extracts that showed direct growth inhibitory activity, the strongest effect was shown by Arctostaphylos uva-ursi (bearberry) leaves against C. violaceum ATCC 31532 (clear zone area of 235 mm 2 ) and C. violaceum NCTC 13274 (207 mm 2 ). The antibacterial activity of Arctostaphylos uva-ursi against Pseudomonas aeruginosa was recently revealed (24) , and according to the data presented, this medicinal plant, traditionally used as an antimicrobial for urinary tract complaints including cystitis and urolithiasis, can be recommended as an antibacterial agent against both C. violaceum and P. aeruginosa, which cause severe and often fatal infections in humans and animals (25) .
The diffusion test results showed the prominent growth-inhibition activity of aqueous extracts of Vaccinium vitis-idaea, Eucalyptus viminalis and Chelidonium majus (clear zones areas 31, 19 and 9 mm 2 , respectively). Further, in the growth inhibition assay, the ethanolic extracts showed a more pronounced activity, which led to the enlargement of ).
Achillea millefolium, Bidens tripartita, Matricaria chamomilla, Plantago major, Taraxacum fficinale, Tussilago farfara
and Viola tricolor did not show any activity.
growth inhibition zones in comparison with aqueous extracts (except for Arctostaphylos uva-ursi), and also the appearance of clear areas around wells filled with ethanolic extracts of Salvia officinalis (25-31 mm 2 ), Ledum palustre (19-31 mm 2 ) and Betula verrucosa (9-19 mm 2 ), with no effect around control wells filled with 45 % ethanol. In turn, the wild-type C. violaceum strain was slightly more sensitive than the reporter and was more inhibited by ethanolic plant extracts than aqueous extracts. Correlation analysis of growth inhibition rates showed a very high degree of conformity between the antibacterial activity of aqueous (R = 0.998, p < 0.001) and ethanolic plant extracts (R = 0.994, p < 0.001). These extracts showed similar activity against both wild-type and mutant C. violaceum strains; significant correlation coefficients showed equal sensitivity of C. violaceum ATCC 31532 and C. violaceum NCTC 13274 to the extracts of the same plant. Thus, the initial screening of twenty species of Eastern-European medicinal plants showed direct antimicrobial activity for seven of them, which explains their traditional use as cures for inflammations and infection-associated diseases. The majority of plant extracts, however, had no effect on the growth of the tested microorganisms, indicating the presence of indirect antimicrobial effects, such as QS-regulatory activity.
Regulatory effects of plant extracts on C. violaceum pigment production
The integral agar-diffusion assay exhibited several effects of plant extracts on violacein production, which were not completely identical in wild-type and reporter C. violaceum biotests.
Surprisingly, many plants stimulated violacein production by the wild-type C. violaceum ATCC 31532 strain and showed an intensive purple halo around wells filled with aqueous or ethanolic extracts against a light purple background. To investigate the nature of this effect in the presence of AHL-like compounds that mimic the native bacterial autoinducer, plant extracts were tested against the C. violaceum NCTC 13274 reporter, without C 6 -AHL supplementation. Among twenty species of Eastern-European medicinal plants, only aqueous and ethanolic extracts of Bidens tripartita (three-lobe beggarticks) induced a concentric purple halo. This finding may hint at the conjecture of some plants being producers of specific compounds that mimic bacterial signal activities and operate as QS agonists (26); this especially holds for plant-bacteria symbiotic interactions. However, our experience of screening a multitude of extracts has provided the impression that an increase in the violacein content was more often caused by unknown non-specific mechanisms, possibly via the addition of nutritional substrates, which led to more rapid increases in cell density and the development of QS communication. Furthermore, the stimulation of pigment production by C. violaceum NCTC 13274 supplemented with C 6 -AHL was reduced, probably because of the initially high autoinducer levels in the cultivation environment.
Subsequent analysis revealed various degrees of violacein inhibition, resulting in a viable but colorless zone, by 11 of the 20 screened plants (Table II) , which showed anti--QS activity more ubiquitously than direct antibacterial activity. Here, we report for the first time the prominent anti-QS properties of Betula verrucosa buds (non-pigmented zone area of 89-113 mm 2 ), while direct antibacterial properties of birch extracts were shown earlier (27) . We are also reporting the anti-QS activity of Eucalyptus viminalis leaves (75-276 mm 2 ), which agree well with data on the anti-QS properties of Eucalyptus oil (28) as well as a significant reduction in QS-mediated biofilm formation by Eucalyptus globulus extracts (29) . Finally, we have confirmed the anti-QS activity of Quercus robur cortex (74-94 mm 2 ) previously described by Adonizio et al. (30) in Quercus virginiana.
Loss of violacein content was shown on the border of growth inhibition zones around wells filled with aqueous and ethanolic extracts of Arctostaphylos uva-ursi leaves (non--pigmented zone area 126-189 mm 2 ). These data agree with the findings showing that Arctostaphylos uva-ursi decreases the QS-mediated elastolytic and proteolytic properties of P. aeruginosa without effects on pyocyanin and pyoverdin formation (24) , which is complementary to the direct antimicrobial effect of this medicinal plant (see above).
Aqueous extracts of Vaccinium vitis-idaea and Ledum palustre showed a decrease in the C 6 -AHL-mediated violacein content in the reporter strain C. violaceum NCTC 13274 (non-pigmented zone areas 83 and 19 mm 2 , respectively), but were inactive against the wild-type strain where a 31-mm 2 violacein inhibition zone was induced by the Juniperus communis aqueous extract. Ethanolic extracts of these medical plants were able to reduce pigmentation in both C. violaceum biotests. Further, as shown in Table II , noticeable violacein inhibition was only observed with ethanolic but not with aqueous extracts of Inula helenium, Calendula officinalis, Comarum palustre and Rosa majalis. Thus, we have confirmed that the type of extractant plays a role for the level of medicinal plant bioactivity (29) . This explains the use of ethanolic extracts in Eastern European (in particular, Russian) ethnomedicine.
Correlation analysis of violacein inhibition data showed more significant correlations for C. violaceum ATCC 31532 (R = 0.926, p < 0.001) and C. violaceum NCTC 13274 (R = 0.904, p < 0.001) strains treated with aqueous or ethanolic plant extracts than comparative effects of aqueous (R = 0.749, p < 0.01) or ethanolic (R = 0.790, p < 0.01) extracts against both strains. Hence, the results demonstrate the complementary character of wild-type and reporter C. violaceum biotests and reveal the total anti-QS properties of the screened medicinal plants.
Comparative antibacterial and regulatory activities of plant extracts
As several plant extracts showed both antibacterial and anti-QS activities, the statistical relationship among them was analysed. The Pearson correlation coefficient for C. violaceum ATCC 31532 and C. violaceum NCTC 13274 strains treated with aqueous or ethanolic plant extracts was calculated, and the results of two random variables were shown as numerical values and linear dependences for data sets. The correlation between antibacterial (S gi -area of growth inhibition, mm 2 ) and anti-QS (S pi -area of pigment inhibition, mm 2 ) variables for the C. violaceum ATCC 31532 strain was statistically significant. Correlation coefficients for aqueous and ethanolic extracts were R = 0.642 and R = 0.706 (p < 0.01), respectively, i.e. both extracts types showed both activities in the wild-type biotest. However, no accurate linear relationship could be established between the two variables. This points to the probable simultaneous presence of both antibacterial and anti-QS activities in plant extracts, but also indicates the absence of their strong interdependence. Also, in C. violaceum NCTC 13274 reporter strain, the statistical relationships between antibacterial and anti-QS variables became statistically insignificant. Correlation coefficients for the interrelationships between these parameters were R = 0.430 for aqueous and R = 0.358 for ethanolic extracts and could not be linearized correctly. The data thus demonstrate differences between antibacterial and anti-QS plant compounds; they function as growth inhibitors or as receptors of AHL signals, respectively.
In addition, we performed comparative analyses of antibacterial and anti-QS activities of medicinal plants according to the Angiosperm Phylogeny Group (31) classification. We have shown that predominantly antibacterial and anti-QS plants were located on different branches of the phylogenetic tree of core eudicots and were united in two partially overlapping groups (Fig. 2) . The most prominent antibacterial plants were put into the asterid clade, order Ericales, indicating the similarity of their evolutionarily developed anti-infection strategy via direct suppression of pathogen growth. In turn, the prominent anti-QS plants were put into the rosid clade with the closest ties between the Quercus and Betulla genera, both related to the order Fagales. Eucalyptus viminalis (rosid clade, order Myrtales) combined these activities as both antibacterial and anti-QS medicinal plant.
These data thus confirm the differences between predominant antibacterial and anti--QS properties in various source plants. Therefore, the dependence of these bioactivities on plant phylogeny provides a basis for further bioinformatic assessments of antibacterial and regulatory compounds.
Anti-QS fractions isolated from Quercus robur cortex extract
The Quercus robur cortex that showed prominent anti-QS activity without detectable antibacterial activity was chosen for the analysis of bioactive compounds.
Chromatographic separation of the dried extract was performed by means of one--step liquid chromatography on a reversed-phase column under low pressure conditions. Separation of total extracts enabled us to obtain several mixed fractions characterized by the presence of hydrophobic (fraction A) and hydrophilic (fraction B) components. Our preliminary data allowed us to conclude that fraction A predominately consisted of basic proteins/peptides, glycoproteins/glycopeptides, some polyphenols (pigments, kinones, etc.), while fraction B contained hydrophilic low molecular mass organic compounds.
Analysis of the bioactivity of fractions A and B showed differences in the anti-QS effect against wild-type and reporter C. violaceum strains (Fig. 3) . The A fraction caused a two-fold higher inhibition of violacein production by the wild-type C. violaceum ATCC 31532 strain (non-pigmented zone area 75 mm 2 ) compared to the C. violaceum NCTC 13274 reporter strain (44 mm 2 ), which that acts not only via signal reception but also by suppression of AHL biosynthesis. In turn, fraction B showed a more pronounced effect in both C. violaceum ATCC 31532 and C. violaceum NCTC 13274 biotests (non-pigmented zone area 94 mm 2 in both cases), which suggested the presence of an anti-QS compound as a probable inhibitor of AHL signal reception. These results show that the anti-QS activity in plant extracts might be driven by two or more compounds representing different bioactivity mechanisms.
CONCLUSIONS
Use of plant extracts is common in traditional (folk) medicine for the treatment of infection and inflammation and has stimulated scientific interest in screening programmes for novel bioactive components. Plant drug discovery has been focused on the prevention of microbial growth and direct killing of bacterial pathogens, or against an alternative anti-infective mechanism that uses cell-cell signalling mediated through quorum sensing. To the best of our knowledge, no studies that would evaluate both activities and address their interactions have been performed. Thus, in this study, some Eastern-European medicinal plants were screened for growth inhibition and QS-regulating activities using two C. violaceum strains: wild-type ATCC 31532 and the derived reporter NCTC 13274, which are ideally suited for combined antibacterial and anti-QS activity screening.
Three types of activities and their combinations were shown in 14 of the 20 tested plants: direct antimicrobial growth-inhibitory activity, non-specific and specific pro-QS activity and anti-QS activity. Analyses have shown the effect of combined antibacterial and anti-QS activities in plant extracts, although statistical analysis has also shown differences between these activities, depending on source plant phylogeny.
In conclusion, these data show multi-component anti-infectious mechanisms used naturally for plant-associated bacterial control and inhibition of phytopatogenic bacteria recognized by folk medicine for the treatment of human and animal infections. Thus, the paradigm »one plant -one component -one effect« should be criticized and further studies on the purification of active components and reproduction of medicinal plant activity for anti-infectious drug development based on novel strategies are necessary.
Some Eastern-European medicinal plants whose activity is reported now are promising sources in the search for microbial growth and quorum sensing inhibitors.
Here, we started the separation procedure of the Quercus robur cortex extract, showing prominent anti-QS properties. We are planning to continue experiments to separate the fractions obtained in this study and further identify the structure of active molecules.
